KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to 38.03.

  • Ionis Pharmaceuticals' Interest Coverage Ratio fell 644.88% to 38.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 16.72, marking a year-over-year increase of 2161.08%. This contributed to the annual value of 27.96 for FY2024, which is 5.39% down from last year.
  • Ionis Pharmaceuticals' Interest Coverage Ratio amounted to 38.03 in Q3 2025, which was down 644.88% from 33.99 recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Interest Coverage Ratio registered a high of 98.57 during Q4 2021, and its lowest value of 120.17 during Q4 2022.
  • In the last 5 years, Ionis Pharmaceuticals' Interest Coverage Ratio had a median value of 35.73 in 2024 and averaged 27.41.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Interest Coverage Ratio skyrocketed by 115860.84% in 2021 and then tumbled by 186872.66% in 2024.
  • Ionis Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 98.57 in 2021, then crashed by 221.91% to 120.17 in 2022, then soared by 98.88% to 1.34 in 2023, then crashed by 1868.73% to 26.44 in 2024, then plummeted by 43.82% to 38.03 in 2025.
  • Its Interest Coverage Ratio stands at 38.03 for Q3 2025, versus 33.99 for Q2 2025 and 35.75 for Q1 2025.